These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 29334981)

  • 21. Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 Challenge.
    Nachbagauer R; Shore D; Yang H; Johnson SK; Gabbard JD; Tompkins SM; Wrammert J; Wilson PC; Stevens J; Ahmed R; Krammer F; Ellebedy AH
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29899095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigenic epitopes in the hemagglutinin of Qinghai-type influenza H5N1 virus.
    Rudneva IA; Kushch AA; Masalova OV; Timofeeva TA; Klimova RR; Shilov AA; Ignatieva AV; Krylov PS; Kaverin NV
    Viral Immunol; 2010 Apr; 23(2):181-7. PubMed ID: 20373998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutralizing and protective murine monoclonal antibodies to the hemagglutinin of influenza H5 clades 2.3.2.1 and 2.3.4.4.
    Schuele C; Schmeisser F; Orr M; Meseda CA; Vasudevan A; Wang W; Weiss CD; Woerner A; Atukorale VN; Pedro CL; Weir JP
    Influenza Other Respir Viruses; 2023 May; 17(5):e13152. PubMed ID: 37246149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
    Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and structural characterization of a broadly neutralizing antibody targeting a novel conserved epitope on the influenza virus H5N1 hemagglutinin.
    Du L; Jin L; Zhao G; Sun S; Li J; Yu H; Li Y; Zheng BJ; Liddington RC; Zhou Y; Jiang S
    J Virol; 2013 Feb; 87(4):2215-25. PubMed ID: 23221567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.
    Kamlangdee A; Kingstad-Bakke B; Osorio JE
    J Virol; 2016 Aug; 90(15):6771-6783. PubMed ID: 27194759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation of recombinant phage antibodies targeting the hemagglutinin cleavage site of highly pathogenic avian influenza virus.
    Dong J; Sakurai A; Nomura N; Park EY; Shibasaki F; Ueda H
    PLoS One; 2013; 8(4):e61158. PubMed ID: 23577205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigenic diversity of H5 highly pathogenic avian influenza viruses of clade 2.3.4.4 isolated in Asia.
    Ohkawara A; Okamatsu M; Ozawa M; Chu DH; Nguyen LT; Hiono T; Matsuno K; Kida H; Sakoda Y
    Microbiol Immunol; 2017 May; 61(5):149-158. PubMed ID: 28370432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic and therapeutic efficacy of a chimeric monoclonal antibody specific for H5 haemagglutinin against lethal H5N1 influenza.
    Prabhu N; Prabakaran M; Hongliang Q; He F; Ho HT; Qiang J; Goutama M; Lim AP; Hanson BJ; Kwang J
    Antivir Ther; 2009; 14(7):911-21. PubMed ID: 19918095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.
    Yoshida R; Igarashi M; Ozaki H; Kishida N; Tomabechi D; Kida H; Ito K; Takada A
    PLoS Pathog; 2009 Mar; 5(3):e1000350. PubMed ID: 19300497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.
    Boonnak K; Matsuoka Y; Wang W; Suguitan AL; Chen Z; Paskel M; Baz M; Moore I; Jin H; Subbarao K
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of circulating Asian H5N1 viruses by a newly established monoclonal antibody.
    Du A; Daidoji T; Koma T; Ibrahim MS; Nakamura S; de Silva UC; Ueda M; Yang CS; Yasunaga T; Ikuta K; Nakaya T
    Biochem Biophys Res Commun; 2009 Jan; 378(2):197-202. PubMed ID: 19010309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Broad cross-reactive epitopes of the H5N1 influenza virus identified by murine antibodies against the A/Vietnam/1194/2004 hemagglutinin.
    Kobayashi-Ishihara M; Takahashi H; Ohnishi K; Nishimura K; Terahara K; Ato M; Itamura S; Kageyama T; Tsunetsugu-Yokota Y
    PLoS One; 2014; 9(6):e99201. PubMed ID: 24945805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection of therapeutic H5N1 monoclonal antibodies following IgVH repertoire analysis in mice.
    Gray SA; Moore M; VandenEkart EJ; Roque RP; Bowen RA; Van Hoeven N; Wiley SR; Clegg CH
    Antiviral Res; 2016 Jul; 131():100-8. PubMed ID: 27109194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins.
    Marjuki H; Mishin VP; Chai N; Tan MW; Newton EM; Tegeris J; Erlandson K; Willis M; Jones J; Davis T; Stevens J; Gubareva LV
    J Virol; 2016 Dec; 90(23):10446-10458. PubMed ID: 27630240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and optimized pairing of mouse monoclonal antibodies for detecting hemagglutinin in novel H7 subtype influenza viruses.
    Wang H; Zhou J; Wang D; Huang B; Tan W
    Sci China Life Sci; 2020 Feb; 63(2):279-289. PubMed ID: 31147904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Properties and therapeutic efficacy of broadly reactive chimeric and humanized H5-specific monoclonal antibodies against H5N1 influenza viruses.
    Zheng Q; Xia L; Wu WL; Zheng Z; Huo Y; Wu J; Liu Y; Yu H; Chen Y; Lau SY; Chen H; Luo W; Xia N
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1349-57. PubMed ID: 21245446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA prime and virus-like particle boost from a single H5N1 strain elicits broadly neutralizing antibody responses against head region of H5 hemagglutinin.
    Wang G; Zhou F; Buchy P; Zuo T; Hu H; Liu J; Song Y; Ding H; Tsai C; Chen Z; Zhang L; Deubel V; Zhou P
    J Infect Dis; 2014 Mar; 209(5):676-85. PubMed ID: 23911711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype.
    Pavlova SP; Veits J; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Aug; 27(37):5085-90. PubMed ID: 19573638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and characterization of mouse-derived monoclonal antibodies against the hemagglutinin of the H1N1 influenza virus.
    Lin X; Yang F; Yan S; Wu H; Wang P; Zhao Y; Shi D; Yao H; Wu H; Li L
    Virus Res; 2024 Jul; 345():199402. PubMed ID: 38772446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.